UNC
Researchers plan to continue to test the gene therapy in younger patients based on Phase I data but are hoping to attract a commercialization partner.
Researchers want drugmakers to clinically test a predictive model that early studies have shown can determine if a patient's tumor is truly dependent on the KRAS pathway.
The Bladder Cancer Advocacy Network organized the UC-GENOME study and is now offering more grant funding to support clinical trials in bladder cancer.
A research consortium in the Carolinas and Virginia is hoping to improve lung cancer prevention and personalized treatment in Black Americans.
Carisma Therapeutics Begins Study of CAR Macrophage Therapy for HER2-Overexpressing Solid Tumors
The study will assess the safety and feasibility of manufacturing CT-0508, the first CAR-engineered macrophage therapy to enter clinical trials.